Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Boyd Steven
Relationship:   10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   18    
Direct Shares   47,075,098    

Indirect Shares

  40,287,245      
Direct Value   $131,704,255    

Indirect Value

  $41,714,873      
Total Shares   87,362,343      
Total Value   $173,419,128      


Avalo Therapeutics, Inc
 $14,783 Dynatronics Corp
 $233,800 Kiora Pharmaceuticals
 $625,814 Fresh Tracks Therapeutics Ord Shs
 $1,466,920 Alimera Sciences Inc
 $2,115,480 Cassava Sciences Inc
 $38,178,981 Bio-Path Holdings, Inc.
 $46,806 AYTU BIOSCIENCE, INC
 $3,946,591 Achieve Life Sciences Inc
 $4,218,880 AMAG Pharmaceuticals Inc
 $56,650,000 Onconova Therapeutics, Inc.
 $596,192 Vaxart Inc
 $139,527 Tenax Therapeutics Inc
 $524,997 Cyclo Therapeutics, Inc
 $22,114,077 ReShape Lifesciences Inc
 $831,407 Avalo Therapeutics, Inc
 $14,783 Dynatronics Corp
 $233,800 Kiora Pharmaceuticals
 $625,814 Fresh Tracks Therapeutics Ord Shs
 $1,466,920 Alimera Sciences Inc
 $2,115,480 Cassava Sciences Inc
 $38,178,981 Bio-Path Holdings, Inc.
 $46,806 AYTU BIOSCIENCE, INC
 $3,946,591 Achieve Life Sciences Inc
 $4,218,880 AMAG Pharmaceuticals Inc
 $56,650,000 Onconova Therapeutics, Inc.
 $596,192 Vaxart Inc
 $139,527 Tenax Therapeutics Inc
 $524,997 Cyclo Therapeutics, Inc
 $22,114,077 ReShape Lifesciences Inc
 $831,407
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    99   
    96    

     Stock price went up :

    54   
    46    
     Stock price went down :
    45   
    50    
   
     Gain/Loss Ratio :
   1.2   
   1.2   
     Percentage Gain/Loss :
   -16.7%
 8,928.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Avalo Therapeutics, Inc AVTX 10% Owner 2023-06-27 34,370 2023-06-27 731,458    Premium*  
            Dynatronics Corp DYNT 10% Owner 2017-03-21 500,000 2017-03-21 1,000,000    Premium*  
            Kiora Pharmaceuticals KPRX 10% Owner 2021-01-06 3,346,601 2021-08-02 785,000    Premium*  
            Fresh Tracks Therapeutics Ord Shs FRTX 10% Owner 2019-01-10 2,170,000 2019-01-10 2,170,000    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2018-02-06 6,936,000 2018-02-06 6,936,000    Premium*  
            Cassava Sciences Inc SAVA 10% Owner 2018-10-03 1,651,340 2018-10-03 0    Premium*  
            Del Friscos Restaurant Group, Llc DFRG 10% Owner 2019-09-25 0 2019-09-25 0    Premium*  
            Valeritas Holdings Inc VLRX 10% Owner 2019-12-20 0 2019-12-20 0    Premium*  
            Bio-Path Holdings, Inc. BPTH 10% Owner 2019-01-18 129,298 2019-01-18 129,298    Premium*  
            AYTU BIOSCIENCE, INC AYTU Director 2021-03-29 1,342,378 2021-03-29 1,342,378    Premium*  
            Achieve Life Sciences Inc ACHV 10% Owner 2019-06-11 843,776 2019-06-11 843,776    Premium*  
            AMAG Pharmaceuticals Inc AMAG 10% Owner 2020-03-16 4,120,000 2020-03-16 348,000    Premium*  
            Onconova Therapeutics, Inc. ONTX 10% Owner 2019-09-23 816,702 2019-09-23 816,702    Premium*  
            Vaxart Inc VXRT Director 2020-06-29 145,523 2020-06-29 145,523    Premium*  
            Tetraphase Pharmaceuticals Inc TTPH Director, 10% Owner 2020-07-28 0 2020-07-28 0    Premium*  
            Tenax Therapeutics Inc TENX Director, 10% Owner 2020-09-08 2,019,995 2020-09-08 2,019,995    Premium*  
            Cyclo Therapeutics, Inc CYTH 10% Owner 2020-09-30 15,795,769 2020-09-30 15,795,769    Premium*  
            ReShape Lifesciences Inc RSLS 10% Owner 2021-06-28 7,223,346 2021-06-28 7,223,346    Premium*  
* Premium Members only  

Records found :    790         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 32
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
ACHV Achieve Life Sciences Inc 10% Owner   –       –       •   2019-05-30 3 IO $0.00 $0 D/D 0 1,095,926 -
ACHV Achieve Life Sciences Inc 10% Owner   –       –       •   2019-05-30 3 IO $0.00 $0 I/I 0 1,095,926 -
ACHV Achieve Life Sciences Inc 10% Owner   –       –       •   2019-06-11 4 B $3.80 $48,689 D/D 12,813 1,026,000 2.37 -
ACHV Achieve Life Sciences Inc 10% Owner   –       –       •   2019-06-11 4 S $0.00 $0 I/I (0) 796,594 0 -
ACHV Achieve Life Sciences Inc 10% Owner   –       –       •   2019-06-11 4 S $2.85 $134,821 D/D (47,182) 796,594 0 -
ACHV Achieve Life Sciences Inc 10% Owner   –       –       •   2019-06-11 4 S $0.00 $0 I/I (0) 843,776 0 -
ACHV Achieve Life Sciences Inc 10% Owner   –       –       •   2019-06-11 4 S $2.53 $837,467 D/D (264,963) 843,776 0 -
ACHV Achieve Life Sciences Inc 10% Owner   –       –       •   2019-06-11 4 B $0.00 $0 I/I 0 1,026,000 1.42 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2018-02-02 4 B $0.00 $0 I/I 0 6,924,000 1.42 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2018-02-02 4 B $1.16 $9,280 D/D 8,000 6,924,000 2.37 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2018-02-05 4 B $0.00 $0 I/I 0 6,928,000 1.42 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2018-02-05 4 B $1.14 $4,560 D/D 4,000 6,928,000 2.37 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2018-02-06 4 B $0.00 $0 I/I 0 6,936,000 1.42 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2018-02-06 4 B $1.12 $8,960 D/D 8,000 6,936,000 2.37 -
AMAG AMAG Pharmaceuticals Inc 10% Owner   –       –       •   2019-06-25 3 IO $0.00 $0 I/I 0 3,501,984 -
AMAG AMAG Pharmaceuticals Inc 10% Owner   –       –       •   2019-06-25 4 B $0.00 $487,050 I/I 55,000 180,000 1.5 -
AMAG AMAG Pharmaceuticals Inc 10% Owner   –       –       •   2019-06-25 3 IO $0.00 $0 D/D 0 3,376,984 -
AMAG AMAG Pharmaceuticals Inc 10% Owner   –       –       •   2019-06-25 4 B $8.59 $2,224,947 D/D 259,016 3,636,000 2.45 -
AMAG AMAG Pharmaceuticals Inc 10% Owner   –       –       •   2019-06-26 4 B $0.00 $0 I/I 0 3,756,000 1.42 -
AMAG AMAG Pharmaceuticals Inc 10% Owner   –       –       •   2019-06-26 4 B $9.13 $1,095,600 D/D 120,000 3,756,000 2.45 -
AMAG AMAG Pharmaceuticals Inc 10% Owner   –       –       •   2019-06-27 4 B $0.00 $189,400 I/I 20,000 200,000 1.5 -
AMAG AMAG Pharmaceuticals Inc 10% Owner   –       –       •   2019-06-27 4 B $9.52 $418,880 D/D 44,000 3,800,000 2.45 -
AMAG AMAG Pharmaceuticals Inc 10% Owner   –       –       •   2019-08-07 4 B $0.00 $297,200 I/I 40,000 240,000 1.5 -
AMAG AMAG Pharmaceuticals Inc 10% Owner   –       –       •   2019-08-07 4 B $7.32 $1,903,200 D/D 260,000 4,060,000 2.45 -
AMAG AMAG Pharmaceuticals Inc 10% Owner   –       –       •   2020-01-09 4 B $0.00 $0 I/I 0 4,060,000 1.42 %

  790  Records found
  1  2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32      
  Page 1 of 32  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed